QARE
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
QARE - overview
Established
2016
Location
Paris, -, France
Primary Industry
Healthcare IT
About
Based in France, QARE is a telemedicine platform that facilitates remote healthcare consultations, offering patients timely access to medical professionals across various specialties. QARE, founded in 2016 and headquartered in Paris, France, provides an online medical teleconsultation service. The company has completed 5 deals, with its most recent deal occurring on April 12, 2021, when it was acquired by HealthHero from Kamet Ventures for undisclosed financial terms. The CEO is Olivier Thierry, and the founder is Alexandre Maisonneuve.
QARE is a leading online medical teleconsultation platform that provides access to healthcare services seven days a week. Its core offering consists of virtual consultations with a diverse range of healthcare professionals, including general practitioners, psychiatrists, psychologists, pediatricians, and gynecologists. Each consultation allows patients to discuss their health concerns via video, with an average waiting time of 30 minutes. The service is designed to enhance accessibility to healthcare, enabling patients to receive medical advice, diagnoses, and prescriptions from the comfort of their homes.
QARE serves a broad customer base across France, with over 2,000 registered doctors and millions of consultations completed. The platform is particularly beneficial for those seeking immediate medical attention without the need for physical visits, catering specifically to urban areas and regions where access to healthcare may be limited. In the most recent year, QARE reported a revenue of EUR 7,226,686. 20, with an EBITDA of EUR -21,137,495.
50. The company generates revenue through a structured pricing model that includes direct-to-consumer consultations, with standard pricing set at EUR 25 for general practitioner visits in sector 1, adhering to French healthcare regulations. The company also utilizes a tiered pricing structure for other specialties, allowing flexibility based on the practitioner's classification. Key components of its revenue model involve the application of the third-party payment system, which eliminates upfront costs for patients covered by the social security system and have complementary health insurance.
This arrangement simplifies the transaction process for users, encouraging higher utilization of teleconsultation services. QARE's offerings are designed to meet both individual and institutional needs, including specialized services for universities and nursing homes, ensuring a broad market reach and a diverse revenue stream. QARE plans to leverage its recent funding of EUR 28. 00 mn to enhance its telemedicine offerings and expand into new markets.
Specific focus areas include the introduction of new products designed to improve user experience. Additionally, QARE is exploring opportunities to expand its geographic reach beyond France, though specific regions and timelines have not yet been disclosed. The recent acquisition by HealthHero is expected to facilitate these growth initiatives.
Current Investors
Kamet Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare, Healthcare IT, Medical Software
Website
www.qare.fr
Verticals
HealthTech, Mobile Apps
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.